Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04070144Not ApplicableCompleted

The First Puncture Success Rate of a Novel Injeq IQ-Tip™ System in Pediatric Lumbar Punctures

Role: lead

NCT02602912Not ApplicableCompleted

Identification of Spine Structures by Using BIP-Needles

Role: lead

NCT02620228Not ApplicableCompleted

Identification of Liver Tumours Using BIP - Biopsy System

Role: lead

NCT02792660Not ApplicableCompleted

Identification of Cerebrospinal Fluid With Injeq IQ-Needle During Paediatric Lumbar Puncture

Role: lead

NCT02605928Not ApplicableCompleted

Use of BIP-Needles in Rheumatologic Injections

Role: lead

All 5 trials loaded